CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Cash Flow from Operating Activities:
Net Income Attributable to the Company	$ 29,940	$ 78,509	$ 114,973
Adjustments to Reconcile Net Income Attributable to the Company to Net Cash Provided by Operating Activities:
Depreciation and Amortization	20,581	19,063	15,797
Amortization of Intangible Liabilities to Income Property Revenue	(404)	(1,754)	(2,383)
Amortization of Deferred Financing Costs to Interest Expense	586	454	444
Amortization of Discount on Convertible Debt	1,278	1,379	1,357
Gain on Disposition of Real Estate and Intangible Lease Assets and Liabilities	(28,316)	(7,509)	(3,296)
Gain on Disposition of Assets Held for Sale		(2,590)	(18,697)
Gain on Sale of Equity Interest in Joint Ventures			(127,518)
Loss on Disposition of Commercial Loan and Master Lease Investments		353
Loss (Gain) on Extinguishment of Debt	3,431	(1,141)
Impairment Charges	17,599	9,147
Accretion of Commercial Loan and Master Lease Investment Origination Fees	(2)	(161)	(135)
Non-Cash Imputed Interest	(438)	(428)	(218)
Deferred Income Taxes	(3,038)	(90,532)	35,100
Unrealized (Gain) Loss on Investment Securities	(10,340)	8,240	(61)
Non-Cash Compensation	3,168	2,786	2,688
Decrease (Increase) in Assets:
Refundable Income Taxes	(416)	(26)	225
Assets Held for Sale	833		3,893
Land and Development Costs	6,391	(493)	(1,107)
Mitigation Credits and Mitigation Credit Rights	(15,750)	3,323	(1,861)
Other Assets	(3,191)	(1,802)	(3,479)
Increase (Decrease) in Liabilities:
Accounts Payable	(370)	(340)	349
Accrued and Other Liabilities	5,680	3,402	490
Deferred Revenue	1,186	(2,511)	(540)
Liabilities Held for Sale	(831)		(49)
Income Taxes Payable		(439)	439
Net Cash Provided By Operating Activities	27,577	16,930	16,411
Cash Flow from Investing Activities:
Acquisition of Real Estate and Intangible Lease Assets and Liabilities	(256,381)	(167,811)	(150,705)
Acquisition of Commercial Loan Investments and Master Lease Investments	(364)	(28,235)	(34,296)
Acquisition of Mitigation Credits		(3,621)
Restricted Cash Balance Received in Acquisition of Interest in Joint Venture	596
Cash Received from (Contribution to) Joint Ventures	23,864	(41)	(84)
Proceeds from Disposition of Property, Plant, and Equipment, Net, and Assets Held for Sale	129,461	85,621	207,552
Proceeds from Sale of Equity Interests in Joint Ventures			96,132
Principal Payments Received on Commercial Loan and Master Lease Investments		22,965
Acquisition of Investment Securities	(143)		(15,500)
Net Cash Provided By (Used In) Investing Activities	(102,967)	(91,122)	103,099
Cash Flow from Financing Activities:
Proceeds from Long-Term Debt	314,500	66,640	141,500
Payments on Long-Term Debt	(283,519)	(72,269)	(103,073)
Cash Paid for Loan Fees	(1,587)	(2,187)	(635)
Payments for Exercise of Stock Options and Common Stock Issuance	(162)
Proceeds from Issuance of Preferred Stock, Net of Underwriting Discount and Expenses	72,430
Cash Used to Purchase Common Stock	(2,210)	(4,100)	(41,096)
Cash Paid for Vesting of Restricted Stock	(436)	(502)	(303)
Cash Paid for Equity Issuance Costs	(197)
Dividends Paid - Preferred Stock	(2,325)
Dividends Paid - Common Stock	(23,580)	(14,470)	(2,198)
Net Cash Provided By (Used In) Financing Activities	72,914	(26,888)	(5,805)
Net Increase (Decrease) in Cash and Cash Equivalents	(2,476)	(101,080)	113,705
Cash and Cash Equivalents, Beginning of Period	33,825	134,905	21,200
Cash and Cash Equivalents, End of Period	31,349	33,825	134,905
Reconciliation of Cash to the Consolidated Balance Sheets:
Cash and Cash Equivalents	8,615	4,289	6,475
Restricted Cash	22,734	29,536	128,430
Total Cash	$ 31,349	$ 33,825	$ 134,905